Supplementary Table S2 from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Authors :: Takuro Sakagami
Sho Saeki
Shiho Ishizuka
Kimitaka Akaike
Takayuki Jodai
Shinji Iyama
Ryo Sato
Koichi Saruwatari
Shinya Sakata
Tokunori Ikeda
Yusuke Tomita
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Indications and characteristics of probiotic CBT in NSCLC patients (N=39).

Full Text Access

Tools